TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).

Sophie Matheron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.